Furthermore, patients with bone marrow syndrome who also have diabetes exhibit a higher mutation rate of the 10-11 translocation 2 (TET2) and splicing factor 3b subunit 1 gene (SF3B1), which correlates with a more severe prognosis (14). The gene discussed is TET2; the disease is diabetes mellitus.